You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‐blinded, placebo‐controlled, phase II clinical trial
|
---|---|
Published in |
Cancer Communications, December 2017
|
DOI | 10.1186/s40880-017-0263-y |
Pubmed ID | |
Authors |
Rui-Hua Xu, Lin Shen, Ke-Ming Wang, Gang Wu, Chun-Mei Shi, Ke-Feng Ding, Li-Zhu Lin, Jin-Wan Wang, Jian-Ping Xiong, Chang-Ping Wu, Jin Li, Yun-Peng Liu, Dong Wang, Yi Ba, Jue-Ping Feng, Yu-Xian Bai, Jing-Wang Bi, Li-Wen Ma, Jian Lei, Qing Yang, Hao Yu |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 51 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 16% |
Student > Bachelor | 4 | 8% |
Student > Doctoral Student | 3 | 6% |
Lecturer | 3 | 6% |
Student > Master | 3 | 6% |
Other | 5 | 10% |
Unknown | 25 | 49% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 14% |
Nursing and Health Professions | 6 | 12% |
Biochemistry, Genetics and Molecular Biology | 5 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Sports and Recreations | 2 | 4% |
Other | 2 | 4% |
Unknown | 27 | 53% |